Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 24:ciaf522.
doi: 10.1093/cid/ciaf522. Online ahead of print.

Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study

Genevieve Walls  1 , Loughlin McGrath  1   2 , Michael Trent Herdman  1 , Anita J Campbell  3   4   5 , Matthew P Cheng  6 , Michael Marks  7   8   9 , Jaap Ten Oever  10 , Euna Sahng  11 , Dafna Yahav  12   13 , Steven Y C Tong  14   15 , Anna L Goodman  16   17 , Anecita Gigi Lim  18 , Max Bloomfield  19 ; Staphylococcus aureus Network Adaptive Platform Trial Early Oral Switch Domain Specific Working Group
Collaborators, Affiliations

Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study

Genevieve Walls et al. Clin Infect Dis. .

Abstract

Background: There is growing evidence to support partial oral antibiotic treatment of severe infections such as Staphylococcus aureus bacteremia, but clinical practice is slow to adopt this paradigm. We know little about how patients with severe infection experience and perceive intravenous and oral antibiotics in terms of quality of life and clinical effectiveness. We performed a qualitative study to elicit patients' views on treatment with intravenous and oral antibiotics, aiming to provide insights that could inform collaborative treatment decision-making.

Methods: We conducted semi-structured interviews with participants in the Staphylococcus aureus Network Adaptive Platform trial pharmacological sub-study PR-O-SNAP by telephone, in person, or via video conferencing. Interviews were recorded, transcribed and coded, and used to analyse and identify themes. Interviews occurred in two phases between November 2024 and January 2025, with interim analysis to refine interview questions between each phase.

Results: We interviewed 17 patients who had received sequential intravenous then oral antibiotics for treatment of Staphylococcus aureus bacteremia. Overall, most participants preferred oral antibiotics for their convenience, which enabled improved mobility and independence, despite a perception that oral regimens were more complex and likely to cause side effects, and that intravenous antibiotics were more effective.

Conclusions: Choosing a route of antibiotic administration for treatment of severe infection is a nuanced decision which should incorporate not just a patient's clinical status, but also their preferences and personal context. Patient convenience and functional goals should be considered in treatment discussions between clinicians and patients.

Keywords: Staphylococcus aureus bacteremia; intravenous antibiotics; oral antibiotics; patient preference.

PubMed Disclaimer